Remove 2000 Remove Patients Remove Safety Remove Treatment
article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.

article thumbnail

Why is US Cannabis Research Funded to Focus on Adverse Effects?

Veriheal

billion was funded into cannabis research between 2000 and 2018. On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. How could we move the focus towards understanding the benefits?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80
article thumbnail

3 Reasons Why Vaporizers Might Be a Better Option Than Smoking Cannabis

Medicinal Marijuana Association

As the number of people seeking medical marijuana treatment grows, safety issues about side effects will likely remain hot topics. While eating or drinking the herb are the safest ways to use cannabis, the following reasons explain why vaporizing has become a viable alternative for medical marijuana patients.

article thumbnail

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Cannabis Law Report

Nutt will lead Awakn’s neuroscience research of psychedelic compounds for treating a broad range of addictions where the consequences for the patient, their family, and society are at present most severe. Nutt’s existing role as Chair of Awakn’s Scientific Advisory Board, Prof.

article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

sat on the Denver County Court bench 2000-2015. She has also served as the past chair of ABA National Conference of Specialized Court Judges; the President of the American Judge’s Association and the Colorado Women’s Bar Association Foundation, and, as a National Highway Traffic Safety Administration (NHTSA) Judicial Outreach Liaison.

article thumbnail

Article: In the Weeds: Marijuana Legalization & Employment Laws

Cannabis Law Report

respondents said marijuana use should be legal, compared to 31 percent who supported legalization in the year 2000. [1] Over the last several years, attitudes towards marijuana use have rapidly changed in the United States. According to a 2018 Pew Research Survey, 62 percent of U.S. Some states are considering adopting similar protections.

Law 40